AtriCure, Inc.
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
AtriCure, Inc.
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
atricure.com
7555 Innovation Way, Mason, 45040, US
Details
Year founded
2000
Revenue
200M-500M
Employees
201-500
Number of locations
5
NAICS
334510
SIC
3841
Products & Services
Outlines the company's specialized services and operational strengths.
- Ablation Devices
- AtriClip Device
- Atrial Fibrillation Treatment Solutions
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- Ablation Sensing Unit & Switch Matrix
- Coolrail® Linear Pen
- cryoFORM® Cryoablation Probe
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
TRUE
Our production algorithm is showing that atricure is ramping up production.
Target industries
Employees working in AtriCure, Inc.
News
AtriCure (NASDAQ:ATRC) Stock Rating Reaffirmed by Needham & Company LLC
AtriCure (NASDAQ:ATRC) Stock Rating Reaffirmed by Needham & Company LLC
Needham & Company LLC reissued a "buy" rating and issued a $40.00 target price on shares of AtriCure in a report on Monday.
Locations (6)
AtriCure, Inc.
7555 Innovation Way, Mason, 45040, US
AtriCure, Inc.
3875 Hopyard Rd Unit 160 Pleasanton, California 94588, US
Atricure
7697 Innovation Way, Mason, OH 45040
AtriCure Warehouse
7697 Innovation Way, Mason, OH 45040
AtriCure, Inc.
3A Chater Road Level 16, The Hong Kong Club Building Central, HK
AtriCure, Inc.
130 Cheshire Ln #250, Minnetonka, MN 55305
Frequently Asked Questions
What services & capabilities does AtriCure, Inc. offer?
AtriCure, Inc. offers a range of services and capabilities, including Ablation Devices.
What kind of equipment does AtriCure, Inc. use?
AtriCure, Inc. uses a variety of equipment, including Ablation Sensing Unit & Switch Matrix.
What are the target industries of AtriCure, Inc.?
AtriCure, Inc. serves several industries, including the medical industry.
How many locations does AtriCure, Inc. operate?
AtriCure, Inc. operates from 5 locations.
What is the annual revenue of AtriCure, Inc.?
AtriCure, Inc.'s revenue is $330.38M.
Where are the headquarters of AtriCure, Inc.?
The headquarters of AtriCure, Inc. are located in 7555 innovation way, mason, ohio 45040, united states.
What is the NAICS code for AtriCure, Inc.?
The NAICS code for AtriCure, Inc. is 334510.
How many employees does AtriCure, Inc. have?
AtriCure, Inc. has 260 employees.
What is the official website of AtriCure, Inc.?
The official website of AtriCure, Inc. is https://www.atricure.com.
When was AtriCure, Inc. founded?
AtriCure, Inc. was founded in 2000.